TRIHEALTH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1852-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.trihealth.com
Clinical Trials
100
Active:1
Completed:65
Trial Phases
5 Phases
Phase 1:1
Phase 2:5
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials
Not Applicable
44 (67.7%)Phase 4
11 (16.9%)Phase 2
5 (7.7%)Phase 3
4 (6.2%)Phase 1
1 (1.5%)Vitamin D and Hypertensive Disorders of Pregnancy
Not Applicable
Not yet recruiting
- Conditions
- Hypertensive Disorders of Pregnancy
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 594
- Registration Number
- NCT07017920
Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics
Not Applicable
- Conditions
- SurgeryPain, Postoperative
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 308
- Registration Number
- NCT06957990
- Locations
- 🇺🇸
Bethesda Surgery Center, Cincinnati, Ohio, United States
Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime
Not Applicable
- Conditions
- Diaper Dermatitis
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 320
- Registration Number
- NCT06958003
- Locations
- 🇺🇸
Good Samaritan Hospital, Cincinnati, Ohio, United States
Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure
Not Applicable
Not yet recruiting
- Conditions
- Human Immunodeficiency Virus
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT06889142
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Phase 3
Recruiting
- Conditions
- Postoperative Urinary Retention (POUR)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- TriHealth Inc.
- Target Recruit Count
- 166
- Registration Number
- NCT06843538
- Locations
- 🇺🇸
TriHealth, Cincinnati, Ohio, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
No news found